Literature DB >> 7616251

Parallel induction of nitric oxide and tetrahydrobiopterin synthesis by cytokines in rat glial cells.

N Sakai1, S Kaufman, S Milstien.   

Abstract

Activation of monocyte-derived macrophages with cytokines leads to the induction of nitric oxide synthase. Much less is known about the effects of cytokines on microglia, resident brain macrophages, or on astrocytes. In this study, we compared the induction by lipopolysaccharide, interferon-gamma, and tumor necrosis factor-alpha of nitric oxide production and synthesis of tetrahydrobiopterin, the required cofactor for nitric oxide synthase, in microglia and peritoneal macrophages. Activation of microglia induced parallel increases in nitric oxide and intracellular tetrahydrobiopterin levels, although induction of the latter appears to be somewhat more sensitive to diverse stimulators. As with macrophages, inducible nitric oxide production in microglia was blocked by inhibitors of tetrahydrobiopterin biosynthesis. Interleukin-2, an important component of the neuroimmunomodulatory system, was only a weak activator of microglia by itself but potently synergized with interferon-gamma to stimulate production of both nitric oxide and tetrahydrobiopterin. Astrocytes were also activated by lipopolysaccharide and combinations of cytokines but showed a somewhat different pattern of responses than microglia. Biopterin synthesis was increased to higher levels in astrocytes than in microglia, but maximal induction of nitric oxide production required higher concentrations of cytokines than microglia and the response was much lower. These results suggest that tetrahydrobiopterin synthesis in glial cells is a potential target for therapeutic intervention in acute CNS infections whose pathology may be mediated by overproduction of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616251     DOI: 10.1046/j.1471-4159.1995.65020895.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Neurodegeneration or neuroprotection: the pivotal role of astrocytes.

Authors:  Simon J R Heales; Amanda A J Lam; Andrew J Duncan; John M Land
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 2.  Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin.

Authors:  T Nagatsu; H Ichinose
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

3.  Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat.

Authors:  H W Clement; J Buschmann; S Rex; C Grote; C Opper; D Gemsa; W Wesemann
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 4.  Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.

Authors:  Augusta Pisanu; Laura Boi; Giovanna Mulas; Saturnino Spiga; Sandro Fenu; Anna R Carta
Journal:  J Neural Transm (Vienna)       Date:  2018-03-14       Impact factor: 3.575

5.  Neurodegeneration and glia response in rat hippocampus following nitro-L-arginine methyl ester (L-NAME).

Authors:  G J Harry; R Sills; M J Schlosser; W E Maier
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

6.  Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Andrea Lopez-Lopez; Carmen M Labandeira; Jose L Labandeira-Garcia; Ana Muñoz
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

Review 7.  Arginine-dependent immune responses.

Authors:  Adrià-Arnau Martí I Líndez; Walter Reith
Journal:  Cell Mol Life Sci       Date:  2021-05-26       Impact factor: 9.261

8.  Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people.

Authors:  Ying Zhang; Chunying Li; Kai Li; Ling Liu; Zhe Jian; Tianwen Gao
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

Review 9.  Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Vanessa X Tan; Gilles J Guillemin
Journal:  Front Neurosci       Date:  2019-09-20       Impact factor: 4.677

Review 10.  The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia.

Authors:  Pia M Vidal; Rodrigo Pacheco
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.